These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21667222)

  • 21. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine.
    Duh MS; Andermann F; Paradis PE; Weiner J; Manjunath R; Crémieux PY
    Dis Manag; 2007 Aug; 10(4):216-25. PubMed ID: 17718660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic equivalency of generic antiepileptic drugs: results of a survey.
    Wilner AN
    Epilepsy Behav; 2004 Dec; 5(6):995-8. PubMed ID: 15582850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy.
    Haskins LS; Tomaszewski KJ; Crawford P
    Epilepsy Behav; 2005 Aug; 7(1):98-105. PubMed ID: 15961350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generic substitution for brand name antiepileptic drugs: a survey.
    Guberman A; Corman C
    Can J Neurol Sci; 2000 Feb; 27(1):37-43. PubMed ID: 10676586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current approaches to the use of generic antiepileptic drugs.
    Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
    Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of specifying brand-name antiepileptic drugs.
    Ng YT
    Arch Neurol; 2009 Nov; 66(11):1415-6. PubMed ID: 19901176
    [No Abstract]   [Full Text] [Related]  

  • 28. Generic anticonvulsant use in children: do we have evidence to recommend brand formulations?
    Hamiwka LD
    Arch Neurol; 2009 Nov; 66(11):1417-8. PubMed ID: 19901177
    [No Abstract]   [Full Text] [Related]  

  • 29. [Generic drugs in the treatment of epilepsy].
    González de Dios J; Ochoa-Sangrador C; Sempere AP
    Rev Neurol; 2005 Dec 1-15; 41(11):676-83. PubMed ID: 16317637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic substitution of antiepileptic drugs.
    Sander JW; Ryvlin P; Stefan H; Booth DR; Bauer J
    Expert Rev Neurother; 2010 Dec; 10(12):1887-98. PubMed ID: 21091318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational use of generic psychotropic drugs.
    Carbon M; Correll CU
    CNS Drugs; 2013 May; 27(5):353-65. PubMed ID: 23620145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient perception of generic antiepileptic drugs in the Midwestern United States.
    Papsdorf TB; Ablah E; Ram S; Sadler T; Liow K
    Epilepsy Behav; 2009 Jan; 14(1):150-3. PubMed ID: 18845274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE; Tomson T
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing bioequivalence of generic modified-release antiepileptic drugs.
    Johnson EL; Chang YT; Davit B; Gidal BE; Krauss GL
    Neurology; 2016 Apr; 86(17):1597-604. PubMed ID: 27016518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM; Ignjatovic Ristic D
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are generic drugs really inferior medicines?
    Moore N; Berdaï D; Bégaud B
    Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
    Odi R; Franco V; Perucca E; Bialer M
    Epilepsia; 2021 Feb; 62(2):285-302. PubMed ID: 33426641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What's the problem with generic antiepileptic drugs?: a call to action.
    Berg MJ
    Neurology; 2007 Apr; 68(16):1245-6. PubMed ID: 17438211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.